STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Area of Science:

• Molecular Biology
• Cellular Biology
• Cancer Research

Background:

• Smad and STAT proteins are key regulators of cell growth and tumorigenesis.
• Transforming growth factor-beta (TGF-β) signaling plays a crucial role in cellular processes.
• Dysregulation of these pathways is implicated in various diseases, including cancer and inflammation.

Purpose of the Study:

• To investigate the interplay between STAT3 and Smad3 signaling pathways.
• To elucidate the mechanism by which STAT3 affects TGF-β-induced cellular responses.
• To understand the implications of this crosstalk in the context of tumor development and inflammation.

Main Methods:

• In vivo and in vitro interaction studies to confirm STAT3-Smad3 binding.
• Assessment of TGF-β-mediated transcriptional and physiological responses upon STAT3 modulation.
• Analysis of Smad3-Smad4 complex formation and Smad3 DNA-binding ability.
• Identification of the specific STAT3 domain involved in the interaction.

Main Results:

• Activated STAT3 directly interacts with Smad3, attenuating TGF-β signaling.
• STAT3 depletion enhances TGF-β-induced cell cycle arrest, apoptosis, and epithelial-to-mesenchymal transition.
• The interaction inhibits Smad3-Smad4 complex formation and suppresses Smad3 DNA-binding.
• The N-terminal DNA-binding domain of STAT3 mediates this interaction and inhibition.

Conclusions:

• A direct crosstalk exists between STAT3 and Smad3 signaling pathways.
• STAT3 negatively regulates TGF-β-induced cellular responses through Smad3 interaction.
• This molecular mechanism may contribute to tumor progression and inflammatory processes.